What is Krishna Institute of Medical Sciences Ltd's PE ratio?

Krishna Institute of Medical Sciences Ltd trades at a P/E ratio of 141.00.

What is Krishna Institute of Medical Sciences Ltd's market cap?

Krishna Institute of Medical Sciences Ltd's market capitalisation is ₹29,476 Cr.

When are Krishna Institute of Medical Sciences Ltd's next results?

Krishna Institute of Medical Sciences Ltd's next earnings date is 4 Nov '26.

What is Krishna Institute of Medical Sciences Ltd's ROE?

Krishna Institute of Medical Sciences Ltd's return on equity (ROE) is 11.3%.

What sector is Krishna Institute of Medical Sciences Ltd in?

Krishna Institute of Medical Sciences Ltd (KIMS) is classified in the Healthcare sector (Hospital).

Healthcare · Hospital

Krishna Institute of Medical Sciences Ltd (KIMS)

₹701.80

Mkt cap

₹29,476 Cr

P/E ratio

141.00

P/B

12.49

Div yield

0.00%

ROE

11.30%

ROCE

9.50%

EPS (TTM)

₹4.98

Book value

₹56

52W range

576–858

Sector

Healthcare

Price history

Previous close

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

NSE KIMSBSE 543308

Health check

Cautious

ValuationExpensive

ProfitabilityWeak

GrowthHigh

TechnicalsNeutral

52-week range

−18.21% from high

₹702

₹576+21.88% from low₹858

Current

₹701.80

Prev close

₹702.50

Day

−0.10%

Price performance

+0.92%

+6.58%

−7.92%

−12.15%

+6.57%

−1.56%

YTD

+11.00%

Financials

Revenue, profit & margin

P/E ratio

141.0×

KIMS is 218% above the sector median of 44.4×

KIMS141.0×

Sector median44.4×

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	606	652	606	634	688	777	772	797	872	961	998	1,075	1,180
Expenses	449	475	459	475	509	559	585	599	679	757	799	868	956
Operating Profit	157	177	147	159	179	218	187	198	193	204	199	206	223
OPM %	26%	27%	24%	25%	26%	28%	24%	25%	22%	21%	20%	19%	19%
Other Income	3	3	3	4	5	5	18	15	7	4	5	1	17
Interest	9	9	12	16	18	20	26	27	33	45	57	68	83
Depreciation	32	33	35	46	39	41	45	53	53	66	79	85	101
Profit before tax	119	139	102	100	127	162	135	134	114	97	69	55	57
Tax %	27%	27%	25%	28%	25%	26%	31%	21%	25%	26%	24%	40%	34%
Net Profit	87	101	77	72	95	121	92	106	85	72	52	33	37
EPS in Rs	2.02	2.30	1.80	1.64	2.16	2.68	2.22	2.54	1.96	1.67	1.33	1.06	0.99
Raw PDF

Earnings

Results dates & reactions

Next results

4 Nov '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.47% · closed higher next day 15 of last 22

	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25	Q4FY25	Q1FY26	Q2FY26	Q3FY26†	Q4FY26†	Q1FY27
Broadcast	7 Nov '23◦	3 Feb '24◦	17 May '24◦	7 Aug '24◦	9 Nov '24◦	6 Feb '25◦	12 May '25◦	6 Aug '25	7 Nov '25	6 Feb '26◦	15 May '26◦	3 Aug '26◦
Earnings day	−0.93%	−2.55%	+3.24%	+2.38%	−1.26%	−1.81%	+1.15%	+1.79%	+1.08%	+8.65%	−5.88%	−3.01%
+1 day	+0.09%	−0.66%	+2.19%	+4.39%	−2.74%	−6.35%	−1.77%	+0.32%	−2.69%	+9.19%	−2.70%	−2.25%
+5 days	−1.29%	−0.91%	−3.73%	+8.03%	−0.52%	−11.12%	−1.93%	−1.28%	−7.68%	+15.00%	−0.64%	−0.92%
+15 days	+3.12%	+4.67%	−1.52%	+18.24%	+6.73%	−20.72%	+3.65%	−2.26%	−4.89%	+20.67%	+2.62%	−5.86%
+30 days	+4.88%	−7.55%	+10.73%	+27.74%	+3.23%	−2.43%	−3.79%	+0.53%	−11.25%	+6.03%	+9.11%	−6.57%
Filing	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Sep 2026

32.65%Promoter

Promoters32.65%0.16

FIIs15.01%0.26

DIIs33.22%1.20

Public19.10%0.78

Ownership trend

Peers

8 companies

Valuation vs quality

P/E × ROCE · bubble = market cap

Name	CMP	P/E	Mkt Cap	Div Yld	NP Qtr	Qtr Profit Var	Sales Qtr	Qtr Sales Var	ROCE
Apollo Hospitals	₹8,448.00	57.74	1,21,469	0.24%	610	+34.17%	7,044	+20.56%	17.45%
Manipal Health	₹669.15	99.41	88,018	0.00%	243	−7.86%	3,091	+38.12%	12.10%
Max Healthcare	₹860.00	58.93	83,705	0.23%	414	−15.54%	2,569	+20.31%	14.71%
Aster DM Quality	₹681.15	164.50	59,374	0.44%	29	−46.12%	1,311	+21.60%	11.57%
Fortis Health.	₹768.15	54.36	57,992	0.13%	273	+3.39%	2,545	+17.46%	13.45%
Narayana Hrudaya	₹1,720.20	38.85	35,154	0.26%	301	+16.61%	2,844	+73.01%	15.50%
Global Health	₹1,270.30	59.66	34,156	0.04%	157	−0.18%	1,304	+26.50%	17.37%
Krishna Institu.	₹701.80	141.33	29,476	0.00%	37	−47.20%	1,180	+35.33%	9.50%
Median: 31 Co.	₹509.20	44.38	6,363	0.00%	30	+17.80%	403	+22.28%	14.62%

Filings

Annual reports6

Annual Report 2026 Annual Report 2025 Annual Report 2024 Annual Report 2023 Annual Report 2022 Annual Report 2022

Credit ratings6

Rating update 29 Juncrisil Rating update 4 Maycrisil Rating update 12 Jancare Rating update 8 Aug 2025crisil Rating update 23 Jul 2025crisil Rating update 30 Apr 2024crisil

Announcements5

Announcement under Regulation 30 (LODR)-Updates on Acquisition 29 Oct - KIMS acquires 51% stake in Sarvottam Health Care for ₹79.5 crore; transfer pending.Announcement under Regulation 30 (LODR)-Updates on Acquisition 29 Oct - KIMS acquired 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 crore in Sangli.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Oct - Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Sachin Salvi - Chief Financial Officer, …General Announcement 28 Oct - Supreme Court dismissed SLP on Chennai hospital lease dispute; project continues without injunction.Board Meeting Intimation for To Consider And Approve The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 02Nd Quarter And Half-Year Ended September 30, 2026. 26 Oct - Board meets November 4, 2026 to approve Q2 and half-year FY2027 results; trading window closedOctober 1.